胎儿基因治疗用于婴儿神经退行性疾病
研究以神经元病性戈谢病(nGD)小鼠模型验证胎儿颅内注射AAV载体可重建神经元葡萄糖脑苷脂酶表达,小鼠存活至少18周且神经退行性变消失;新生儿干预亦有效但较差;并证明超声引导下对胎猴脑全局AAV基因转移可行。
要点
- 胎儿期颅内AAV注射可重建nGD小鼠神经元酶表达并延长存活。
- 胎儿干预消除神经退行性变并改善神经炎症,效果优于新生儿干预。
- 超声引导胎猴脑全局AAV基因转移可行,支持临床转化探索。
核心结论
- 胎儿颅内注射AAV载体可重建nGD小鼠神经元葡萄糖脑苷脂酶表达并消除神经退行性变。
- 新生儿干预亦可 rescue 小鼠但效果不及胎儿干预。
- 超声引导下胎猴脑全局AAV基因转移可行,为临床转化提供依据。
研究设计与样本
- 研究采用携带loxP-flanked neomycin disruption of Gba及K14启动子调控Cre重组酶的nGD小鼠模型。
- 对胎鼠行颅内注射AAV载体,并与新生儿期干预比较。
- 另在胎猴中验证超声引导下全局AAV基因转移的可行性。
主要发现
- 胎鼠干预后小鼠存活至少18周,具有生育能力且完全活动。
- 胎鼠干预使神经退行性变消失并改善神经炎症。
- 新生儿干预亦 rescue 小鼠但效果较差。
- 胎猴脑超声引导全局AAV基因转移可行。
临床怎么用
- 为nGD等早发性致死神经遗传病提供胎儿期基因治疗转化研究方向。
- 胎儿干预可能优于新生儿干预,支持产前治疗窗口探索。
局限性
- 主要证据来自nGD小鼠模型,人体疗效与安全性未验证。
- 胎猴仅验证基因转移可行性,未报告长期安全性与疗效数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
For inherited genetic diseases, fetal gene therapy offers the potential of prophylaxis against early, irreversible and lethal pathological change. To explore this, we studied neuronopathic Gaucher disease (nGD), caused by mutations in GBA. In adult patients, the milder form presents with hepatomegaly, splenomegaly and occasional lung and bone disease; this is managed, symptomatically, by enzyme replacement therapy. The acute childhood lethal form of nGD is untreatable since enzyme cannot cross the blood-brain barrier. Patients with nGD exhibit signs consistent with hindbrain neurodegeneration, including neck hyperextension, strabismus and, often, fatal apnea1. We selected a mouse model of nGD carrying a loxP-flanked neomycin disruption of Gba plus Cre recombinase regulated by the keratinocyte-specific K14 promoter. Exclusive skin expression of Gba prevents fatal neonatal dehydration. Instead, mice develop fatal neurodegeneration within 15 days2. Using this model, fetal intracranial injection of adeno-associated virus (AAV) vector reconstituted neuronal glucocerebrosidase expression. Mice lived for up to at least 18 weeks, were fertile and fully mobile. Neurodegeneration was abolished and neuroinflammation ameliorated. Neonatal intervention also rescued mice but less effectively. As the next step to clinical translation, we also demonstrated the feasibility of ultrasound-guided global AAV gene transfer to fetal macaque brains.
引用
- Massaro G, Mattar CNZ, Wong AMS, et al. Fetal gene therapy for neurodegenerative disease of infants. Nat Med. 2018. PMID: 30013199. doi:10.1038/s41591-018-0106-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。